Enzolve Technologies Ltd., established in 2002, is a privately owned Irish biotechnology company, which spun-out from the School of Biomolecular and Biomedical Science (University College Dublin).

Enzolve develops engineered enzymes and applies them in the healthcare and life sciences markets.

Enzolve also develops newborn screening tests NeoScreenPak for the diagnosis of inborn errors of metabolism.

Enzolve utilizes its expertise in enzyme technology for a variety of specialist applications including:

• clinical diagnostics / screening

• asymmetric synthesis

• protein detection

• customised expert biochemical services

The Company is led by an expert management team that includes top scientists and leading business professionals.